ARCHIVES

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

This article is from The Cancer Letter archive.

Vol. 17 No. 07 | February 15, 1991

Download PDF Visit The Full Archive

Related Articles

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Gallo’s Deputy Removed Pending Investigation

January 11, 1991